Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease

Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays

(2021) Argonde C. Harten et al.   Alzheimers & Dementia

Parkinson disease-associated cognitive impairment

(2021) Dag Aarsland et al.   Nature Reviews Disease Primers

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

(2020) David J. Irwin et al.   ANNALS OF NEUROLOGY

Amyloid-β and tau biomarkers and clinical phenotype in dementia with Lewy bodies

(2020) Daniel Ferreira et al.   NEUROLOGY

Multimodal in vivo and postmortem assessments of tau in Lewy body disorders

(2020) David G. Coughlin et al.   NEUROBIOLOGY OF AGING

Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS

(2019) Leslie M. Shaw et al.   CLINICAL BIOCHEMISTRY

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

(2019) Oskar Hansson et al.   Alzheimers Research & Therapy

Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers

(2019) Tessandra Stewart et al.   JOURNAL OF ALZHEIMERS DISEASE

Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays

(2019) Kaj Blennow et al.   Scientific Reports

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

(2018) Tanya Simuni et al.   MOVEMENT DISORDERS

CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders

(2018) David J. Irwin et al.   NEUROLOGY

Finding useful biomarkers for Parkinson’s disease

(2018) Alice S. Chen-Plotkin et al.   Science Translational Medicine

Current state of Alzheimer’s fluid biomarkers

(2018) José Luis Molinuevo et al.   ACTA NEUROPATHOLOGICA

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

(2018) Kenneth Marek et al.   Annals of Clinical and Translational Neurology

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study

(2017) Anette Schrag et al.   LANCET NEUROLOGY

Cognitive decline in Parkinson disease

(2017) Dag Aarsland et al.   Nature Reviews Neurology

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

(2017) Chelsea Caspell-Garcia et al.   PLoS One

Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies

(2016) A W Lemstra et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia

(2016) Yosef Berlyand et al.   PLoS One

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

(2015) Osama Sabri et al.   Alzheimers & Dementia

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

(2015) Daniel Weintraub et al.   MOVEMENT DISORDERS

Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic Review

(2015) Katherine Leaver et al.   NEUROPSYCHOLOGY REVIEW

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

pROC: an open-source package for R and S+ to analyze and compare ROC curves

(2011) Xavier Robin et al.   BMC BIOINFORMATICS

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

The epidemiology of dementia associated with Parkinson disease

(2009) Dag Aarsland et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES